Simon Says

SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax


Listen Later

David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax’s […]
...more
View all episodesView all episodes
Download on the App Store

Simon SaysBy Business RadioX ®

  • 5
  • 5
  • 5
  • 5
  • 5

5

1 ratings